Swift Biosciences, Inc.

Industry

  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
  • Biotechnology
    • Drug Discovery Technologies
      • Bioinformatics
      • Genomics-Proteomics
  • Research, Analytical Equipment & Supplies
See more in Biomedtracker

Latest on Swift Biosciences, Inc.

In Vivo

Execs On The Move, March 2017

 
• By Regina Paleski

Company Changes ABI-SAAB , Walid, MD To: Galapagos NV , CMO (March) From: Shire Pharmaceuticals, Group VP, Global Clin. Dev., Therapeutic Area Head, GI, Endocrinology & Metabolism Phone: +32 15

Medtech Insight

Medtech Start-Up Quarterly Statistics, Q4 2013

Financings In the fourth quarter of 2013, start-up companies raised an aggregate of $1.18 billion, more than double Q3’s $559.4 million. That total is the highest we’ve seen in five years; 89% ($1.04

Scrip

Start-Up Quarterly Statistics, Q4 2013

 
• By Deanna Kamienski

Financings In the fourth quarter of 2013, start-up companies raised an aggregate of $1.18 billion, more than double Q3’s $559.4 million. That total is the highest we’ve seen since START-UP began fea

Scrip

Start-Up Execs On The Move, November 2013

 
• By Regina Paleski

Start-Up Execs Abide Therapeutics Inc. Gary O’Neill, PhD To: VP, Biology (October) From: VP, & Discovery Site Head, Merck Research Laboratories Phone: 858-427-2590 Akebia Therapeutics Inc.